When devices containing radioactive sources or ionising radiation generators are made available on the market, suppliers shall provide the purchaser with adequate information on the potential radiological risks associated with their use and on the conditions of use, testing and maintenance, together with a demonstration that the design allows exposure to ionising radiation to be reduced to as low a level as reasonably achievable.
Furthermore, in the case of medical devices emitting ionising radiation, this information shall be supplemented by adequate information on the assessment of the risks to patients and on the available evidence from the evaluation of clinical data within the meaning of Article 61 of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 concerning medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC, in accordance with procedures specified by regulation.